All groups
- 1 membersMicrosoft, which has been hit with more than 1.6 billion euros ($1.
- 1 membersWASHINGTON, March 23 (Reuters) - Treasury Secretary Janet Yellen said on Thursday the United States was looking at ways to strengthen its sanctions against Iran, but acknowledged the sanctions had not resulted in the behavioral or policy changes.
- 1 membersWalmart has been investing heavily in automation over the past few years, partnering with automation companies such as Knapp to help it cut down the number of steps it takes employees to process e-commerce orders to five from 12, which has been.
- 1 membersTAIPEI, March 23 (Reuters) - Taiwan Foreign Minister Joseph Wu said on Thursday that President Tsai Ing-wen's meeting with U.S. House Speaker Kevin McCarthy in the United States is still in the process of being arranged.
- 1 membersMarch 23 (Reuters) - The United States has designated one former and two current Paraguayan officials for what Washington said was their involvement in "significant corruption," making the officials and their families ineligible for entry into the.
- 1 membersThe International Olympic Committee (IOC) sanctioned Russia and Belarus after Moscow's invasion of Ukraine in February 2022 but is now reluctant to exclude their athletes from the Olympics entirely for fear of a return to the boycotts of the Cold.
- 1 membersThe United States has been shoring up alliances in the Asia-Pacific seeking to counter China's assertiveness in the South China Sea and the Taiwan Strait, as Beijing seeks to advance its territorial claims.
- 1 membersOTTAWA, March 24 (Reuters) - The United States and Canada pledged to work together on several issues, including migration, defense and security, the two countries said on Friday after a meeting between U.S.
- 1 membersMarch 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol.
- 1 membersThe drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).